https://www.selleckchem.com/pr....oducts/larotrectinib
Despite its clinical relevance, a subclass of acute decompensated heart failure (ADHF) with elevated blood pressure, known as hypertensive ADHF (HT-ADHF), has been less intensively evaluated. This study aimed to characterize the prognostic nature and pathophysiology of HT-ADHF. A total of 509 consecutive patients with first-time ADHF hospitalization were subjects of the study. Participants were divided into two groups an HT-ADHF group (systolic blood pressure, SBP 140 mmHg at presentation) and a non-HT-ADHF group (SBP ≤ 140 m